A detailed history of Massmutual Trust CO Fsb transactions in Organon & Co. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 2,077 shares of OGN stock, worth $30,926. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,077
Previous 2,065 0.58%
Holding current value
$30,926
Previous $42,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$18.65 - $23.03 $223 - $276
12 Added 0.58%
2,077 $39,000
Q2 2024

Jul 02, 2024

SELL
$17.45 - $21.96 $261 - $329
-15 Reduced 0.72%
2,065 $42,000
Q1 2024

Apr 09, 2024

BUY
$13.78 - $18.8 $1,805 - $2,462
131 Added 6.72%
2,080 $39,000
Q4 2023

Jan 03, 2024

BUY
$10.95 - $17.32 $3,941 - $6,235
360 Added 22.66%
1,949 $28,000
Q3 2023

Oct 03, 2023

SELL
$16.59 - $23.77 $2,206 - $3,161
-133 Reduced 7.72%
1,589 $27,000
Q2 2023

Aug 01, 2023

BUY
$19.27 - $24.63 $9,692 - $12,388
503 Added 41.26%
1,722 $35,000
Q1 2023

Apr 11, 2023

BUY
$21.42 - $32.08 $3,277 - $4,908
153 Added 14.35%
1,219 $28,000
Q4 2022

Jan 06, 2023

BUY
$23.31 - $28.61 $14,149 - $17,366
607 Added 132.24%
1,066 $30,000
Q3 2022

Oct 07, 2022

BUY
$23.4 - $34.25 $795 - $1,164
34 Added 8.0%
459 $11,000
Q2 2022

Jul 07, 2022

SELL
$31.66 - $38.9 $6,490 - $7,974
-205 Reduced 32.54%
425 $14,000
Q1 2022

Apr 08, 2022

BUY
$30.45 - $39.36 $4,963 - $6,415
163 Added 34.9%
630 $22,000
Q4 2021

Feb 09, 2022

SELL
$28.67 - $37.13 $5,533 - $7,166
-193 Reduced 29.24%
467 $14,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $1,860 - $2,316
-65 Reduced 8.97%
660 $22,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $20,626 - $27,550
725 New
725 $22,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.